CYP19A1 and hyperinsulinemic hypoglycemia, familial, 4: Summary of select studies describing the linear growth response in patients with aggrecan deficiency treated with recombinant human GH (rhGH), with or without addition of another growth targeted intervention (ie, GnRH and/or aromatase inhibitor)